AmnioCyte Plus

AmnioCyte Plus is a **human amniotic fluid allograft** developed by Predictive Biotech for use as a skin and soft tissue substitute in wound management and tissue repair applications. It is described as a **minimally manipulated biological product** regulated under U.S. human cells, tissues, and cellular and tissue-based product frameworks, and is intended for repair, reconstruction, replacement, or supplementation of a recipient's cells or tissue. Its therapeutic rationale appears to derive from the extracellular matrix, soluble biologic factors, and supportive tissue milieu present in amniotic fluid rather than a defined single molecular target, so a precise target-based mechanism of action has not been established from the provided information.

Brand names

AmnioCyte Plus

Other names

amniotic fluid allograftminimally manipulated amniotic fluid allograft